Oropharyngeal Carcinoma
Information
- Disease name
- Oropharyngeal Carcinoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02365844 | Completed | Multispectral Imaging to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyngeal Cancer | February 2015 | August 27, 2018 | |
| NCT01434394 | Completed | Phase 2/Phase 3 | Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer | August 2011 | February 2017 |
| NCT01440270 | Completed | Phase 2 | Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer | August 2011 | February 2017 |
| NCT04788264 | Completed | N/A | Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment | March 28, 2021 | June 29, 2023 |
| NCT05880797 | Recruiting | Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma | July 7, 2023 | August 2026 | |
| NCT03215719 | Recruiting | Phase 2 | Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma | July 10, 2017 | December 2025 |
| NCT03809624 | Recruiting | Phase 2 | Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer | January 30, 2019 | December 2025 |
| NCT04151082 | Recruiting | Phase 1/Phase 2 | High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors | October 31, 2019 | July 31, 2025 |
| NCT05075980 | Recruiting | Phase 2 | HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers | February 16, 2022 | November 15, 2026 |
| NCT05491512 | Recruiting | Phase 2 | A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer | August 4, 2022 | August 4, 2025 |
| NCT04867330 | Recruiting | N/A | Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCC | February 1, 2021 | January 2026 |
| NCT04874493 | Recruiting | Patient Reported Outcome Post Radiation Therapy or Chemoradiotherapy Patient Care in Patients With Oropharyngeal Cancer | March 10, 2021 | February 2, 2027 | |
| NCT04508829 | Unknown status | Phase 2 | Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy | January 1, 2016 | December 1, 2023 |
| NCT04012502 | Unknown status | N/A | De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese Populations | July 1, 2019 | December 31, 2020 |